CrowdStrike CRWD recently announced that it has signed an agreement to acquire the San Francisco-based external attack surface management (EASM) platform provider, Reposify. The buyout is anticipated to conclude in third-quarter fiscal 2023 (August-October 2022), subject to customary closing conditions.
Reposify had secured a place in Gartner’s 2021 ‘Emerging Vendor’ list for its EASM software-as-a-service platform, which spots exposed and vulnerable Internet-facing assets of an entity and protects them from attacks in real time. CrowdStrike will combine its Falcon Threat Intelligence solution portfolio with Reposify’s EASM platform to deliver an adversarial view of enterprise risks across internal and external attack surfaces.
Reposify Complements CrowdStrike’s Product Portfolio
CrowdStrike’s Falcon Intelligence solution integrates threat intelligence into endpoint protection, automatically performing investigations, speeding response and enabling cyber security teams to transform from a reactive to a predictive and proactive state. The EASM solution from Reposify, on the other hand, is mainly focused on reducing the risk exposure of the external assets of the enterprises, preventing shadow IT.
The latest buyout will be a strategic fit for CrowdStrike as Reposify’s product portfolio complements the company’s existing Security and IT Operations product suite. It will offer enterprises a complete view of their external attack surface with just a click.
CrowdStrike is always looking for strategic acquisitions to boost its product portfolio and drive top-line growth. In November 2021, it acquired SecureCircle, a SaaS-based cybersecurity service that extends Zero Trust security to data on the endpoint.
The same year in March, the company acquired high-performance cloud log management technology provider, Humio, to fortify its Extended Detection and Response capabilities. In September 2020, CrowdStrike completed the acquisition of identity theft protection provider, Preempt Security, which has enhanced the company’s Zero Trust security capabilities.
CrowdStrike Price and Consensus
CrowdStrike is benefiting from growing demand for its cyber-security solutions, owing to the slew of data breaches and the increasing necessity for security and networking products amid the ongoing remote working trend across the globe. The company’s rich experience in the security space and continued delivery of mission-critical solutions is aiding it to maintain and grow its market share.
The company has been witnessing top and bottom-line growth for the past several quarters, owing to the strong demand environment for cyber-security solutions along with its sustained focus on enhancing product offerings through in-house research and development, and acquisitions. In the last reported quarter, the company’s revenues soared 58% year over year to $535.2 million while non-GAAP earnings jumped over three-fold to 36 cents per share from 11 cents reported in the year-ago quarter.
Shares of CRWD have lost 34.9% in the past year.
Zacks Rank & Stocks to Consider
CrowdStrike currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader Computer and Technology sector are Clearfield CLFD, Silicon Laboratories SLAB and EPAM Systems EPAM. While Clearfield and Silicon Laboratories flaunt a Zacks Rank #1 (Strong Buy), EPAM carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Clearfield’s fourth-quarter fiscal 2022 earnings has been revised 10 cents north to 80 cents per share over the past 60 days. For fiscal 2022, earnings estimates have moved 36 cents north to $3.13 per share in the past 60 days.
Clearfield’s earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 33.9%. Shares of CLFD have improved 112% in the past year.
The Zacks Consensus Estimate for Silicon Laboratories’ third-quarter 2022 earnings has increased 36% to $1.13 per share over the past 60 days. For 2022, earnings estimates have moved 20.5% up to $4.41 per share in the past 60 days.
Silicon Laboratories’ earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 63.6%. Shares of SLAB have declined 12.1% in the past year.
The Zacks Consensus Estimate for EPAM Systems’ third-quarter 2022 earnings has been revised 7 cents northward to $2.52 per share over the past seven days. For 2022, earnings estimates have moved 15 cents north to $9.96 per share in the past seven days.
EPAM’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 23%. Shares of the company have declined 38% in the past year.
Just Released: Free Report Reveals Little-Known Strategies to Help Profit from the $30 Trillion Metaverse Boom
It’s undeniable. The metaverse is gaining steam every day. Just follow the money. Google. Microsoft. Adobe. Nike. Facebook even rebranded itself as Meta because Mark Zuckerberg believes the metaverse is the next iteration of the internet. The inevitable result? Many investors will get rich as the metaverse evolves. What do they know that you don’t? They’re aware of the companies best poised to grow as the metaverse does. And in a new FREE report, Zacks is revealing those stocks to you. This week, you can download, The Metaverse – What is it? And How to Profit with These 5 Pioneering Stocks. It reveals specific stocks set to skyrocket as this emerging technology develops and expands. Don’t miss your chance to access it for free with no obligation.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
EPAM Systems, Inc. (EPAM): Free Stock Analysis Report
Silicon Laboratories, Inc. (SLAB): Free Stock Analysis Report
Clearfield, Inc. (CLFD): Free Stock Analysis Report
CrowdStrike (CRWD): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.